Literature DB >> 9142014

Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee.

S M Grundy, G J Balady, M H Criqui, G Fletcher, P Greenland, L F Hiratzka, N Houston-Miller, P Kris-Etherton, H M Krumholz, J LaRosa, I S Ockene, T A Pearson, J Reed, R Washington, S C Smith.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9142014     DOI： 10.1161/01.cir.95.9.2329

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  25 in total

1.  The economic burden of physical inactivity in Canada.

Authors:  P T Katzmarzyk; N Gledhill; R J Shephard
Journal:  CMAJ       Date:  2000-11-28       Impact factor: 8.262

2.  Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.

Authors:  J G Fodor; J J Frohlich; J J Genest; P R McPherson
Journal:  CMAJ       Date:  2000-05-16       Impact factor: 8.262

Review 3.  Influenza and cardiovascular disease: is there a causal relationship?

Authors:  Mohammad Madjid; Ibrahim Aboshady; Imran Awan; Silvio Litovsky; S Ward Casscells
Journal:  Tex Heart Inst J       Date:  2004

4.  Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease.

Authors:  Krishna G Aragam; Amanda Dobbyn; Renae Judy; Mark Chaffin; Kumardeep Chaudhary; George Hindy; Andrew Cagan; Phoebe Finneran; Lu-Chen Weng; Ruth J F Loos; Girish Nadkarni; Judy H Cho; Rachel L Kember; Aris Baras; Jeffrey Reid; John Overton; Anthony Philippakis; Patrick T Ellinor; Scott T Weiss; Daniel J Rader; Steven A Lubitz; Jordan W Smoller; Elizabeth W Karlson; Amit V Khera; Sekar Kathiresan; Ron Do; Scott M Damrauer; Pradeep Natarajan
Journal:  J Am Coll Cardiol       Date:  2020-06-09       Impact factor: 24.094

5.  From the patient's perspective: the impact of training on resident physician's obesity counseling.

Authors:  Melanie Jay; Sheira Schlair; Rob Caldwell; Adina Kalet; Scott Sherman; Colleen Gillespie
Journal:  J Gen Intern Med       Date:  2010-03-09       Impact factor: 5.128

Review 6.  [Prevention of coronary heart disease--"evidence-based medicine" of antilipemic therapy].

Authors:  J R Schaefer; M Herzum; B Maisch
Journal:  Herz       Date:  1999-02       Impact factor: 1.443

7.  Overprescribing of lipid lowering agents.

Authors:  M A Smith; E D Cox; J M Bartell
Journal:  Qual Saf Health Care       Date:  2006-08

Review 8.  Innovative approaches to comprehensive cardiovascular disease risk reduction in clinical and community-based settings.

Authors:  N F Gordon; R D Salmon; B S Mitchell; G C Faircloth; L I Levinrad; S Salmon; W E Saxon; K S Reid
Journal:  Curr Atheroscler Rep       Date:  2001-11       Impact factor: 5.113

9.  Lipoprotein subclasses and particle size determined by nuclear magnetic resonance spectroscopy in systemic lupus erythematosus.

Authors:  Cecilia P Chung; Annette Oeser; Paolo Raggi; Joseph F Solus; Ingrid Avalos; MacRae F Linton; Sergio Fazio; C Michael Stein
Journal:  Clin Rheumatol       Date:  2008-04-18       Impact factor: 2.980

Review 10.  [Arteriosclerosis and coronary heart disease--strengths and weaknesses in the classical risk factor concept].

Authors:  J R Schaefer; M Herzum
Journal:  Herz       Date:  1998-05       Impact factor: 1.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.